Japan Graves’ disease market is growing at a CAGR of around 4.7% during the forecast period. According to the WHO, around 10.1% of the country’s population is suffering from diabetes, among which, the individuals suffering from type-1 diabetes are more prone to develop Grave’s disease in the near future. According to IDF, around 2.2 per thousand children and adolescents aged 14 years and below are suffering from type-1 diabetes in Japan. Thus, the prevalence of disease is likely to propel the Japan Graves’ disease market growth during the forecast period.

Visit for Global Graves Disease Market Report at: https://www.omrglobal.com/industry-reports/graves-disease-market

Further, the two regulatory agencies responsible for the Grave’s disease treatment products and services in Japan, includes, Ministry of Health Labor and Welfare (MHLW) and Pharmaceuticals and Medical Devices Agency (PMDA) which are responsible for the laws and regulation for medical devices & drugs and quality of pharmaceuticals and medical devices respectively.

According to the National Centre for Biotechnology Information (NCBI), in 2017, a range of childhood hyperthyroidism cases are accredited under Grave’s disease. Moreover, pediatric patients consist of less than 5% of the total number of patients that are suffering from Grave’s disease, wherein the prevalence rate of the disease in children and adolescents is around 0.02%. In Japan, around 40% of children have a familial history of the Graves’ disease, with frequency rate of 2% to 3%.

Additionally, Japan Thyroid Association is a Tokyo-based organization that consists of a range of scientists that develop guidelines for the diagnosis and management of thyroid nodules. The committee is further organized in the examination of the prevalence of subclinical hypothyroidism in Japan. The organization has provided “Guidelines for the Treatment of Grave’s Disease with Anti-thyroid Drug, in 2006”, stating several standard therapeutic protocols to general physicians for the treatment of Grave’s disease. Thus, such standard set by the government in Japan has created scope for the Japan Graves’ disease market growth in the near future.

Research Methodology

The market study of the Japan Graves’ disease market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Japan Graves’ Disease Market Research and Analysis by Diagnosis
2. Japan Graves’ Disease Market Research and Analysis by Treatment

The Report Covers

• Comprehensive research methodology of the Japan Graves’ disease market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the Japan Graves’ disease market.
• Insights about market determinants which are stimulating the Japan Graves’ disease market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.